Ekso Bionics Holdings Inc (NASDAQ: EKSO) Recovers 13.71% From 52-Week Low, Is EKSO Still A High-Risk, High-Reward Play?

Ekso Bionics Holdings Inc (NASDAQ:EKSO) currently has a daily average trading volume of 2.06M but it saw 1848430 shares traded in last market. With a market cap of 8.09M USD, the company’s current market price of $0.28 came rising about 10.38 while comparing to the previous closing price of $0.25. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.53 and as low as $0.25.

Over the week, EKSO’s stock price is moving -30.35% down while it is -33.62% when we observe its performance for the past one month. Year-to-date it is -54.33% down and over the past year, the stock is showing a downside performance of -78.57%.

The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0. In next quarter, company is expected to be making quarterly sales of $4.15M as analysts are expecting the sales for current fiscal year at $17.61M and seeing the company making $25.06M in sales next year. Moreover, analysts are in estimates of $4.31M for current-quarter revenue.

Currently, Ekso Bionics Holdings Inc’s total number of outstanding shares is 28.20M with 4.24% of that held by the insiders while 13.06% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -64.88% and return on equity (ROE) at -80.71%. Stock’s beta reads 0.96. Stock has a price to book (P/B) ratio of 0.62 while price to sale or P/S ratio amounts to 0.46. Its return on asset (ROA) is -38.36% on average.